Phase I trials typically involve a small number of healthy volunteers, usually ranging between 20 to 100 participants. These individuals are chosen to minimize variability and to ensure that the effects observed can be directly attributed to the intervention. In some cases, particularly with treatments for serious conditions, patients with the condition may be included in this phase.
